Medical Imaging Analysis Software Market By Software Type (Integrated Software, Standalone Software), By Imaging Type (2D Imaging, 3D Imaging, 4D Imaging), By Modality (Tomography, Ultrasound Imaging, Radiographic Imaging, Combined Modalities), By Application (Orthopedic Applications, Dental Applications, Neurology, Cardiology Applications, Oncology Applications, Obstetrics And Gynecology Applications, Mammography Applications, Urology And Nephrology Applications), By End Users (Hospitals, Diagnostic Centers, Research Centers) , Industry Size, Growth, Share And Forecast To 2022
Key Findings
The global medical imaging analysis software market was estimated to grow around $2143.7 million in 2015 and it is forecasted to reach around $3687.55 million at a CAGR of 8.45% during 2015-2022. The major factor driving theglobal medical imaging analysis software market is the rising number of chronic diseases in all over the world like cancer, cardiovascular diseases etc. along with the rising geriatric population has been expected to boost the globalmedical imaging analysis software market in near future.Usageof medical imaging devices is rising in all over the world due to growing technological advancements in medical fieldas well as rising medical tourism is expected to drives this market. The rising adoption of new technologiesand medicines isminimizing the long stay of patients in the hospitals which is boosting the medical imaging analysis software market.The major factordriving the market is therising healthcare industry as well as fusion imaging technologies etc. are fueling the market growth.
As far as region is concerned, Asia Pacific market is expected to grow at higher rate during 2015-2022 with rising healthcare expenditures in developing countries like India, China etc. Although there are many factors which drives the market and still there are various restraints too which are faced by the medical imaging analysis software market such as requirement of high investment and high risk associated with usage of imaging devicesare adversely affecting the market.High market penetration for standalone software vendors and dearth of skilled personnel etc. are the major challenges being faced by market.
Market Segment Insight
The global medical imaging analysis software market is segmented on the basis of software type, image type, modality, application and end user. On the basis of software type, the market is segmented into integrated software; standalone software etc. on the basis of image type, the market is segmented into 2D imaging, 3D imaging and 4D imaging etc. Among all imaging type, 3D imaging is witnessing highest growth in future due to changing lifestyle and technological advancements in all over the world. On the basis of modality, the market is segmented into tomography (computed chromatography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission tomography), ultrasound imaging (2D Ultrasound Systems, 3D and 4D Ultrasound Systems, doppler imaging), and radiographic imaging, combined modalities (PET/CT, SPECT/CT, PET/MR)etc. Among all modality, radiography Imaging market hold the largest market share and dominates the market in 2015 and it is forecasted to grow further over the period of time. On the basis of applications, the market is segmented into orthopedic applications, dental applications, neurology, cardiology applications, oncology applications, obstetrics and gynecology applications, mammography applications, urology and nephrology applications and others. Among all applications, cardiology and oncology applications holds largest market share due to rising number of patients suffering from cardiovascular diseases etc. and it also act as a major driver for the market. On the basis of end user, the market is segmented into hospitals, diagnostics centers, and research centers etc. Among all end users, hospital industry holds the largest market share due to rising healthcare infrastructure across the globe and it also beneficial for the medical imaging analysis software market.
Regional Insight
Based on type this market is segmented into North America, Europe, APAC and Row. North America holds thelargest market share and it is the fastest growing region followed byAsia Pacific, Europe and Row.The major reason behind the growth of market in this region arethe rising number of patients suffering from chronic diseases, rising demand for imaging devices for the betterment of patient in all over the world etc. Asia Pacific region is the fastest growing region for the medical imaging analysis software market due to rising aging population and escalating healthcare industry and it is forecasted to grow significantly in near future. Key players are also focusing on medical imaging analysis software market due to increasing governmental initiatives for the modernization of healthcare infrastructure for getting better response in future.
Competitive Insights
Some of the major market playersAgfa-Gevaert Group (Agfa), Aquilab, Aribex Inc., Carestream Health, Inc. (A Subsidiary Of Onex Corporation), Esaote S.P.A, General Electric Company (Ge), MedvisoAb, Merge Healthcare Inc. (Part Of Ibm Corporation), Mim Software, Inc., Philips Healthcare, Shimadzu Corporation, Siemens Healthcareand so on. Acquisitions, expansions and mergers are the key strategies adopted by the market players to sustain in the market.On 9th November’2015, GE healthcare acquires The Camden Group, one of the leading healthcare advisory firm to transform the healthcare industry.
CHAP 1. METHODOLOGY & SCOPE 15
1.1. RESEARCH METHODOLOGY 15
1.2. RESEARCH SCOPE & ASSUMPTIONS 15
1.3. LIST OF DATA SOURCES 15
CHAP 2. EXECUTIVE SUMMARY 16
2.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET SUMMARY & KEY BUYING CRITERIA 16
2.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET OUTLOOK 16
2.3. MARKET SEGMENTATION ANALYSIS 16
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 16
2.5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET VALUE CHAIN ANALYSIS 16
2.6. VENDOR LANDSCAPE 16
CHAP 3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET 17
3.1. MARKET DRIVER ANALYSIS 17
3.1.1. TECHNOLOGICAL UPGRADATION IN MEDICAL IMAGING ANALYSIS SOFTWARE 17
3.1.2. RISING GERIATRIC POPULATION 17
3.1.3. RISING DEMAND FOR IMAGING DEVICES 17
3.1.4. FUSION OF IMAGING TECHNOLOGIES 17
3.2. MARKET RESTRAINT ANALYSIS 17
3.2.1. REQUIREMENT OF HIGH INVESTMENT 17
3.2.2. HIGH RISK ASSOCIATED WITH USAGE OF IMAGING DEVICES 17
3.3. KEY OPPORTUNITIES 17
3.3.1. RISING AUTOMATED IMAGE ANALYSIS 17
3.3.2. GROWING DEMAND FOR CLOUD-BASED IMAGE ANALYSIS SOLUTIONS 17
3.3.3. UNEXPLORED EMERGING MARKET 17
3.4. CHALLENGES 17
3.4.1. HIGH MARKET PENETRATION FOR STANDALONE SOFTWARE VENDORS 17
3.4.2. DEARTH OF EXPERIENCED AND SKILLED PERSONNEL 17
CHAP 4. INDUSTRY ANALYSIS 18
4.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET– PORTER’S FIVE FORCE MODEL 18
4.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET– PESTEL ANALYSIS 18
4.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET– GAP ANALYSIS 18
CHAP 5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE TYPE 2012-2022 ($ MILLION) 19
5.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY INTEGRATED SOFTWARE 2012-2022 ($ MILLION) 19
5.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY STANDALONE SOFTWARE 2012-2022 ($ MILLION) 19
CHAP 6. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGING TYPE 2012-2022 ($ MILLION) 20
6.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D IMAGING 2012-2022 ($ MILLION) 20
6.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D IMAGING 2012-2022 ($ MILLION) 20
6.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 4D IMAGING 2012-2022 ($ MILLION) 20
CHAP 7. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY 2012-2022 ($ MILLION) 21
7.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY TOMOGRAPHY 2012-2022 ($ MILLION) 21
7.1.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMPUTED TOMOGRAPHY (CT) 2012-2022 ($ MILLION) 21
7.1.1.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HIGH-END SLICE (CT) 2012-2022 ($ MILLION) 21
7.1.1.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MID-END SLICE (CT) 2012-2022 ($ MILLION) 21
7.1.1.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY LOW-END SLICE CT 2012-2022 ($ MILLION) 21
7.1.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAGNETIC RESONANCE IMAGING (MRI) 2012-2022 ($ MILLION) 21
7.1.2.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CLOSED MRI SYSTEMS 2012-2022 ($ MILLION) 21
7.1.2.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OPEN MRI SYSTEMS 2012-2022 ($ MILLION) 21
7.1.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY POSITRON EMISSION TOMOGRAPHY (PET) 2012-2022 ($ MILLION) 22
7.1.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SINGLE-PHOTON EMISSION TOMOGRAPHY (SPECT) 2012-2022 ($ MILLION) 22
7.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ULTRASOUND IMAGING 2012-2022 ($ MILLION) 22
7.2.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D ULTRASOUND SYSTEMS 2012-2022 ($ MILLION) 22
7.2.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D AND 4D ULTRASOUND SYSTEMS 2012-2022 ($ MILLION) 22
7.2.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DOPPLER IMAGING 2012-2022 ($ MILLION) 22
7.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RADIOGRAPHIC IMAGING 2012-2022 ($ MILLION) 22
7.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMBINED MODALITIES 2012-2022 ($ MILLION) 22
7.4.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY PET/CT 2012-2022 ($ MILLION) 22
7.4.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SPECT/CT 2012-2022 ($ MILLION) 22
7.4.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY PET/MR 2012-2022 ($ MILLION) 22
CHAP 8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION 2012-2022 ($ MILLION) 23
8.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ORTHOPEDIC APPLICATIONS 2012-2022 ($ MILLION) 23
8.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DENTAL APPLICATIONS 2012-2022 ($ MILLION) 23
8.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY NEUROLOGY 2012-2022 ($ MILLION) 23
8.4. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CARDIOLOGY APPLICATIONS 2012-2022 ($ MILLION) 23
8.5. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ONCOLOGY APPLICATIONS 2012-2022 ($ MILLION) 23
8.6. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OBSTETRICS AND GYNECOLOGY APPLICATIONS 2012-2022 ($ MILLION) 23
8.7. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAMMOGRAPHY APPLICATIONS 2012-2022 ($ MILLION) 23
8.8. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY UROLOGY AND NEPHROLOGY APPLICATIONS 2012-2022 ($ MILLION) 23
CHAP 9. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END USERS 2012-2022 ($ MILLION) 24
9.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HOSPITALS 2012-2022 ($ MILLION) 24
9.2. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DIAGNOSTIC CENTERS 2012-2022 ($ MILLION) 24
9.3. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RESEARCH CENTERS 2012-2022 ($ MILLION) 24
CHAP 10. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 25
10.1. GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY REGION 2012-2022 ($ MILLION) 25
10.2. NORTH AMERICA 25
10.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 25
10.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.2.3.1. U.S. 25
10.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.2.3.2. CANADA 25
10.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.2.3.3. MEXICO 25
10.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
10.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
10.3. EUROPE 26
10.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 26
10.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.1. GERMANY 26
10.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.2. UK 26
10.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.3. FRANCE 26
10.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.4. ITALY 26
10.3.3.4.1. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
10.3.3.4.2. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
10.3.3.5. REST OF EUROPE 26
10.3.3.5.1. OTHERS MARKET ESTIMATES AND FORECAST2012-2022($ MILLION) 27
10.3.3.5.2. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ MILLION) 27
10.4. ASIA PACIFIC 27
10.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 27
10.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.1. CHINA 27
10.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.2. INDIA 27
10.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.3. JAPAN 27
10.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.4. AUSTRALIA 27
10.4.3.4.1. AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
10.4.3.4.2. AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
10.4.3.5. OTHERS 27
10.4.3.5.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022($ MILLION) 28
10.4.3.5.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022($ MILLION) 28
10.5. REST OF THE WORLD 28
10.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
10.5.3. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 28
10.5.4. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 28
CHAP 11. COMPETITIVE LANDSCAPE 29
11.1. AGFA-GEVAERT GROUP (AGFA) 30
11.1.1. COMPANY OVERVIEW 30
11.1.2. SCOT ANALYSIS 30
11.1.3. PRODUCT BENCHMARKING 30
11.1.4. STRATEGIC INITIATIVES 30
11.2. AQUILAB 30
11.2.1. COMPANY OVERVIEW 30
11.2.2. SCOT ANALYSIS 30
11.2.3. PRODUCT BENCHMARKING 30
11.2.4. STRATEGIC INITIATIVES 30
11.3. ARIBEX INC. 30
11.3.1. COMPANY OVERVIEW 30
11.3.2. SCOT ANALYSIS 30
11.3.3. PRODUCT BENCHMARKING 30
11.3.4. STRATEGIC INITIATIVES 30
11.4. CARESTREAM HEALTH, INC. (A SUBSIDIARY OF ONEX CORPORATION) 30
11.4.1. COMPANY OVERVIEW 30
11.4.2. SCOT ANALYSIS 30
11.4.3. PRODUCT BENCHMARKING 30
11.4.4. STRATEGIC INITIATIVES 30
11.5. ESAOTE S.P.A 30
11.5.1. COMPANY OVERVIEW 30
11.5.2. SCOT ANALYSIS 30
11.5.3. PRODUCT BENCHMARKING 30
11.5.4. STRATEGIC INITIATIVES 30
11.6. GENERAL ELECTRIC COMPANY (GE) 30
11.6.1. COMPANY OVERVIEW 30
11.6.2. SCOT ANALYSIS 31
11.6.3. PRODUCT BENCHMARKING 31
11.6.4. STRATEGIC INITIATIVES 31
11.7. MEDVISO AB 31
11.7.1. COMPANY OVERVIEW 31
11.7.2. SCOT ANALYSIS 31
11.7.3. PRODUCT BENCHMARKING 31
11.7.4. STRATEGIC INITIATIVES 31
11.8. MERGE HEALTHCARE INC. (PART OF IBM CORPORATION) 31
11.8.1. COMPANY OVERVIEW 31
11.8.2. SCOT ANALYSIS 31
11.8.3. PRODUCT BENCHMARKING 31
11.8.4. STRATEGIC INITIATIVES 31
11.9. MIM SOFTWARE, INC. 31
11.9.1. COMPANY OVERVIEW 31
11.9.2. SCOT ANALYSIS 31
11.9.3. PRODUCT BENCHMARKING 31
11.9.4. STRATEGIC INITIATIVES 31
11.10. PHILIPS HEALTHCARE 31
11.10.1. COMPANY OVERVIEW 31
11.10.2. SCOT ANALYSIS 31
11.10.3. PRODUCT BENCHMARKING 31
11.10.4. STRATEGIC INITIATIVES 31
11.11. SHIMADZU CORPORATION 31
11.11.1. COMPANY OVERVIEW 31
11.11.2. SCOT ANALYSIS 31
11.11.3. PRODUCT BENCHMARKING 31
11.11.4. STRATEGIC INITIATIVES 31
11.12. SIEMENS HEALTHCARE 32
11.12.1. COMPANY OVERVIEW 32
11.12.2. SCOT ANALYSIS 32
11.12.3. PRODUCT BENCHMARKING 32
11.12.4. STRATEGIC INITIATIVES 32
11.13. TOSHIBA MEDICAL SYSTEMS CORPORATION 32
11.13.1. COMPANY OVERVIEW 32
11.13.2. SCOT ANALYSIS 32
11.13.3. PRODUCT BENCHMARKING 32
11.13.4. STRATEGIC INITIATIVES 32
11.14. VARIAN MEDICAL SYSTEMS INC. 32
11.14.1. COMPANY OVERVIEW 32
11.14.2. SCOT ANALYSIS 32
11.14.3. PRODUCT BENCHMARKING 32
11.14.4. STRATEGIC INITIATIVE 32
11.15. ZEIHM IMAGING INC. 32
11.15.1. COMPANY OVERVIEW 32
11.15.2. SCOT ANALYSIS 32
11.15.3. PRODUCT BENCHMARKING 32
11.15.4. STRATEGIC INITIATIVES 32
TABLE 1 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SOFTWARE TYPE 2012-2022 ($ MILLION) 32
TABLE 2 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY INTEGRATED SOFTWARE 2012-2022 ($ MILLION) 32
TABLE 3 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY STANDALONE SOFTWARE 2012-2022 ($ MILLION) 32
TABLE 4 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY IMAGING TYPE 2012-2022 ($ MILLION) 33
TABLE 5 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D IMAGING 2012-2022 ($ MILLION) 33
TABLE 6 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D IMAGING 2012-2022 ($ MILLION) 33
TABLE 7 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 4D IMAGING 2012-2022 ($ MILLION) 33
TABLE 8 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MODALITY 2012-2022 ($ MILLION) 33
TABLE 9 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY TOMOGRAPHY 2012-2022 ($ MILLION) 33
TABLE 10 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMPUTED TOMOGRAPHY (CT) 2012-2022 ($ MILLION) 33
TABLE 11 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HIGH-END SLICE (CT) 2012-2022 ($ MILLION) 33
TABLE 12 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MID-END SLICE (CT) 2012-2022 ($ MILLION) 33
TABLE 13 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY LOW-END SLICE CT 2012-2022 ($ MILLION) 33
TABLE 14 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAGNETIC RESONANCE IMAGING (MRI) 2012-2022 ($ MILLION) 33
TABLE 15 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CLOSED MRI SYSTEMS 2012-2022 ($ MILLION) 33
TABLE 16 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OPEN MRI SYSTEMS 2012-2022 ($ MILLION) 33
TABLE 17 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY POSITRON EMISSION TOMOGRAPHY (PET) 2012-2022 ($ MILLION) 33
TABLE 18 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SINGLE-PHOTON EMISSION TOMOGRAPHY (SPECT) 2012-2022 ($ MILLION) 33
TABLE 19 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ULTRASOUND IMAGING 2012-2022 ($ MILLION) 33
TABLE 20 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 2D ULTRASOUND SYSTEMS 2012-2022 ($ MILLION) 33
TABLE 21 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY 3D AND 4D ULTRASOUND SYSTEMS 2012-2022 ($ MILLION) 34
TABLE 22 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DOPPLER IMAGING 2012-2022 ($ MILLION) 34
TABLE 23 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RADIOGRAPHIC IMAGING 2012-2022 ($ MILLION) 34
TABLE 24 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY COMBINED MODALITIES 2012-2022 ($ MILLION) 34
TABLE 25 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY PET/CT 2012-2022 ($ MILLION) 34
TABLE 26 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY SPECT/CT 2012-2022 ($ MILLION) 34
TABLE 27 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY PET/MR 2012-2022 ($ MILLION) 34
TABLE 28 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 29 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ORTHOPEDIC APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 30 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DENTAL APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 31 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY NEUROLOGY 2012-2022 ($ MILLION) 34
TABLE 32 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY CARDIOLOGY APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 33 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY ONCOLOGY APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 34 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY OBSTETRICS AND GYNECOLOGY APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 35 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY MAMMOGRAPHY APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 36 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY UROLOGY AND NEPHROLOGY APPLICATIONS 2012-2022 ($ MILLION) 34
TABLE 37 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY END USERS 2012-2022 ($ MILLION) 34
TABLE 38 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY HOSPITALS 2012-2022 ($ MILLION) 35
TABLE 39 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY DIAGNOSTIC CENTERS 2012-2022 ($ MILLION) 35
TABLE 40 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY RESEARCH CENTERS 2012-2022 ($ MILLION) 35
TABLE 41 GLOBAL MEDICAL IMAGING ANALYSIS SOFTWARE MARKET BY REGION 2012-2022 ($ MILLION) 35
TABLE 42 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 43 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 35
TABLE 44 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 45 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 46 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 47 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 48 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 49 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 50 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 51 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 52 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 35
TABLE 53 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 54 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 55 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 56 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 57 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 58 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 59 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 60 ITALY MARKET ESTIMATES AND FORECAST2012-2022($ MILLION) 36
TABLE 61 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 62 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 63 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 64 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 36
TABLE 65 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 66 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 67 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 68 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 69 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 70 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 71 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 72 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
TABLE 73 AUSTRALIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 37
TABLE 74 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 37
TABLE 75 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 37
TABLE 76 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
TABLE 77 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 37
TABLE 78 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 37
FIGURE 1 MARKET SHARE BY REGIONS 37
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 9 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 10 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 11 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 12 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 13 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 14 AUSTRALIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 15 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 16 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
FIGURE 17 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 38
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)